Skip to content

DRUG

BRIGHT MINDS BIOSCIENCES INC.

NASDAQ · Healthcare · Biotechnology · CA

$60.98
−0.93%
Ask drillr

Next report

Analyst consensus

Next report date
Dec 22, 2026
EPS estimate
-$1.07
Revenue estimate

Latest reported

Last report date
Aug 17, 2026
EPS actual
-$0.17
EPS estimate
-$1.22
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
6
EPS misses (12Q)
0
EPS in line (12Q)
0
Avg surprise (4Q)
+46.9%
Revenue beats (12Q)

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$146
PT range
$145 – $147
Analysts
2
2 Buy0 Hold0 Sell
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 17, 2026-$1.22-$0.17Beat 86.10%
May 20, 2026-$1.17-$0.80Beat 31.62%
Feb 12, 2026-$0.98-$0.70Beat 28.57%
Dec 23, 2025-$0.70-$0.41Beat 41.43%
Aug 14, 2025-$0.59-$0.53Beat 10.17%
Feb 13, 2025-$0.23$0.01Beat 104.35%
Aug 14, 2024$0.04
May 15, 2024-$0.10
Aug 14, 2023-$0.29
May 15, 2023-$0.08
Feb 7, 2023-$0.10
Aug 12, 2022-$0.87

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 22, 2026